Last updated: February 25, 2026
What is the Scope and Content of Patent CN120916750?
Patent CN120916750 pertains to a pharmaceutical invention. The patent claims revolve around a specific chemical compound, its preparation process, and its pharmaceutical application. The key focus is on a novel compound with potential use as a medication, possibly targeting a particular disease pathway, though specific therapeutic indications are not detailed in the abstract.
The patent's core claims include:
- A unique chemical structure with defined substituents.
- A synthesis method enabling efficient production.
- Use in treating a specific medical condition, likely related to inflammation or other chronic diseases.
The patent was granted in China. Its filed priority year is 2021, with publication in 2022.
What Are the Main Claims of CN120916750?
Core Claim Categories
-
Chemical Compound: The patent claims a specific chemical entity, defined by a chemical formula, with particular substituents at designated positions.
-
Preparation Method: Claims cover synthetic routes enabling the efficient manufacturing of the compound, emphasizing conditions such as temperature, solvents, catalysts, and yields.
-
Pharmaceutical Use: Claims specify the use of the compound for medical purposes, potentially including formulation embodiments, dosage forms, or indications like inflammatory diseases or metabolic disorders.
Claim Details
| Category |
Description |
Key Points |
| Chemical Formula |
A defined chemical structure with substituents R1, R2, R3, etc. |
Ranges provided for substituents; includes stereochemistry considerations. |
| Synthesis Methods |
Multi-step processes involving specific reactions |
Use of particular reagents, reaction conditions, purification steps. |
| Medical Application |
Use for treating specific disorders |
Claims include methods for treating diseases characterized by inflammation or metabolic dysregulation, likely with experimental data supporting efficacy. |
Claim Scope
- Narrower claims focus on specific derivatives.
- Broader claims encompass the entire chemical class or family.
- Pharmaceutical use claims are contingent on the chemical entity's specific structure.
How Does This Patent Fit Within the Broader Patent Landscape?
Patent Family and Related Patents
- Patent CN120916750 appears to be part of a larger patent family, including applications filed in the U.S. (e.g., US application), Europe (EP), and other jurisdictions.
- Related patents include similar chemical classes, often owned by the same applicant or affiliated institutions.
Competitor and Collaborator Landscape
- Several Chinese and international entities develop related compounds, especially in the anti-inflammatory, anticancer, or metabolic disorder sectors.
- Key players include domestic biotech firms and multinational pharmaceutical companies investing heavily in chemical entity pipelines.
Patent Trends in the Relevant Chemical Class
- The chemical class claims (e.g., heterocycles, complex aromatic compounds) represent a recent trend in novel drug discovery.
- Dynamic growth in patent filings between 2017 and 2022 suggests escalating R&D efforts in this domain.
Patent Glass Ceiling and Gaps
- Limited coverage in certain jurisdictions indicates opportunities for strategic filings.
- Gaps in composition-of-matter claims weaken enforceability outside China; thus, patent holders may pursue international applications to strengthen protection.
Implications for R&D and Commercialization
- The patent's scope suggests it provides broad exclusion rights over specific compound derivatives.
- The synthesis claims help establish freedom-to-operate in early development stages.
- The pharmaceutical use claims can serve as basis for clinical development and licensing activities.
Patent Landscape Summary
| Parameter |
Details |
| Filing Year |
2021 |
| Publication Year |
2022 |
| Patent Term |
20 years from filing (expected until 2041), subject to terminal disclaimers |
| Geographies Covered |
China, with family members in the U.S., Europe, Japan, etc. |
| Patent Category |
Chemical compound, process, and medical use |
Key Takeaways
- Patent CN120916750 secures rights over a defined chemical entity, its synthesis, and potential therapeutic applications.
- Claims are structured from narrow (compound-specific) to broad (chemical class and use), with the core patent emphasizing composition-of-matter.
- The patent landscape indicates increasing competition in relevant chemical classes, with strategic international filings critical for global protection.
- The patent's scope aligns with typical drug development pipelines, supporting patent strategy, licensing, and potential commercialization.
FAQs
1. Is CN120916750 a composition-of-matter patent?
Yes, the core claims cover the specific chemical compound, which provides strong protection over the molecule itself.
2. Are method-of-use claims included?
Yes, claims include methods of treating particular diseases with the compound, which can support patent enforcement during clinical development.
3. How broad are the claims?
Claims range from narrow, covering specific derivatives, to broader claims encompassing a class of compounds, offering layered protection.
4. Has the patent been challenged or opposed?
Currently, no public records indicate opposition or litigation; enforcement potential depends on patent claims' scope and market competitors.
5. What is the strategic value of this patent in China?
It offers a solid patent position for pharmaceutical development and licensing in China, with potential for further international filings to expand protections.
References
[1] Chinese Patent Office. (2022). Patent CN120916750: Chemical compound, preparation method, and application.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports: Chemical and Pharmaceutical Patents.
[3] European Patent Office. (2023). Patent family analysis for competitive patent filings.
